46.46.Z - Wholesale trade of pharmaceutical and medical products
10.41.Z - Production of oils and other liquid fats
10.89.Z - Production of other food products, not elsewhere classified
20.42.Z - Manufacture of cosmetics and toilet preparations
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
46.39.Z - Wholesale trade of non-specialized food, beverages, and tobacco products
72.11.Z - Scientific research and development activities
72.19.Z - Scientific research and development activities
74.90.Z - Other professional, scientific and technical activities, not elsewhere classified
77.40.Z - Leasing of intellectual property and similar products, excluding works protected by copyright
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | -0,7 | -0,2 | -43,3 | -17 940,2 |
EBITDA | -0,7 | -0,2 | -42,8 | -19 213,2 |
Short time liabilities | 0,2 | 0,4 | 1,3 | 230,9 |
Equity capital | -0,1 | -0,3 | 31,8 | 11 092,6 |
Operating profit (EBIT) | -0,7 | -0,2 | -42,9 | -19 227,9 |
Assets | 0,2 | 0,1 | 33,8 | 33 064,9 |
Net profit (loss) | -0,7 | -0,2 | -43,2 | -18 398,9 |
Cash | 0 | 0 | 2,8 | 981 121,8 |
Net income from sale | 0 | 0 | 2,6 | -∞ |
Liabilities and provisions for liabilities | 0,2 | 0,4 | 2 | 398,8 |
Working assets | 0,2 | 0,1 | 5 | 5081,7 |
Depreciation | 0 | 0 | 0 | -∞ |
% | % | % | p.p. | |
Profitability of capital | 1298,9 | 80,7 | -135,8 | -216,5 |
Equity capital to total assets | -33,6 | -285 | 94,2 | 379,2 |
Gross profit margin | -2242,7 | -1657,2 | 585,5 | |
EBITDA Margin | -2100,3 | -1641,8 | 458,5 | |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 2507 | 2 147 483 648 | 181 | -2 147 483 467 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane